Feb 19, 2021, 01:00 AM by User Not Found

Bio-IT World | Specialized cells in a child’s immune system rapidly target SARS-CoV-2, nasal antiviral blocks transmission in ferrets, machine learning used for drug repurposing, insight into how the virus attacks mucus membrane cells, and a CDC update on anaphylaxis after vaccination. Plus: Fauci on known variants of the virus.

Feb 18, 2021, 01:00 AM by User Not Found

Bio-IT World | The chemistry of tau protein in the brains of Alzheimer’s patients looks different at early and later stages of the disease, suggesting it could serve as a biomarker of disease progression. Although dementia researchers have historically focused almost entirely on abnormal accumulations of beta-amyloid, tau correlates better with cognitive decline and thus understanding its chemistry is key, says Judith Steen, Ph.D., associate professor of neurology at Harvard Medical School.

Feb 17, 2021, 01:00 AM by User Not Found

Bio-IT World | In the modern-day analytical laboratory, chromatography and mass spectrometry (MS) are increasingly seen working side by side. These complementary techniques provide powerful insight into the quantity, size, and structure of a wide range of analytes. But despite the combined power of these systems, the practical instrumentation, data management and reporting are often anything but connected.

Feb 16, 2021, 01:00 AM by User Not Found

Bio-IT World | TRENDS FROM THE TRENCHES | Biopharma’s new superheroes are the data wranglers who have equal access to the rich data sets available through the UK Biobank project. In pharma and biotech, these professionals work at the next level of data management going beyond traditional and straightforward data extraction, transformation, and loading processes to bring knowledge from the data.

Feb 15, 2021, 12:30 PM by

VERICHEM LABORATORIES has announced that it has expanded the available test reporting options that it offers with its Calibration Verification Data Reduction Program.

Feb 15, 2021, 12:30 PM by

Scytek laboratories offers special Stain, Antibodies, Hematology, Microbiology, Hematoxlyn, Nuclei Histology Red Special Stain, Histology ,Nuclear Fast Red Solution, H &E, Eosin, Cytology, Cytoplasm, Collagen, Erythrocytes, DAB Chromogen kit /Substrate Bulk Pack kit Citrate Plus (10x) HIER Solution by scytek

Feb 15, 2021, 12:30 PM by

This announcement is in response to the growing need in the industry for solutions like elluminate CTMS that can automate operational data pipelines and reduce the time spent on manual data tracking processes to accelerate clinical development. ​ ​

Feb 15, 2021, 12:30 PM by

Feb 15, 2021, 12:30 PM by

Feb 15, 2021, 12:30 PM by

Feb 15, 2021, 12:30 PM by

Strategic alliance will streamline patient-centric recruitment for sponsors and CROs, ultimately improving recruitment and retention outcomes in decentralized clinical trials

Feb 15, 2021, 12:30 PM by

Integration of Dotmatics’ ELN with HighRes Biosolutions’ Cellario instrument control software will streamline experiments and workflows Scientists will be able to plan experiments and run instruments from the ELN

Feb 15, 2021, 12:30 PM by

The panel contains serum or peripheral blood mononuclear cells (PBMCs) isolated from pre- and post-vaccination blood samples.

Feb 15, 2021, 12:30 PM by

Antibiotic Research UK (ANTRUK), the UK’s only charity focused on tackling bacterial antibiotic resistance, is urging the UK Government to publish clear national guidelines about whether people on antibiotics should have the COVID-19 vaccination.

Feb 12, 2021, 01:00 AM by User Not Found

Bio-IT World | New machine learning framework estimates asymptomatic cases, helium microscope used to visualize SARS CoV-2, SARS CoV-2 mutations develop in single patient, and new vaccine platforms. Plus: clinicians at UCI Health develop successful system for monoclonal antibody delivery, New Yorkers are responding more favorably to the new COVID-19 vaccine, and old drugs may be repurposed as COVID-19 treatments.

Feb 11, 2021, 01:00 AM by User Not Found

Bio-IT World | Messenger RNA (mRNA) vaccines were the focus of a symposium on COVID-19 vaccines held during last week’s COVID-19 and Cancer virtual meeting of the American Association for Cancer Research. To date, only two vaccines have received Emergency Use Authorization by the U.S. Food and Drug Administration and both are mRNA vaccines—one developed by Moderna and the other by Pfizer and BioNTech.

Feb 10, 2021, 18:53 PM by User Not Found

Bio-IT World | Sema4 announced its planned merger with CM Life Sciences today. The transaction combines Sema4’s leading AI- and machine learning-powered integrated genomic and clinical open-architecture data platform, with CM Life Sciences, a special purpose acquisition company, or SPAC, sponsored by affiliates of Casdin Capital, LLC and Corvex Management LP. The transaction is expected to provide up to $793 million in immediate cash proceeds.

Feb 10, 2021, 01:00 AM by User Not Found

Bio-IT World | The impact of the COVID-19 pandemic on our nation’s blood supply was not very apparent in public discussion. And yet the radical shifts in the demand for blood products, and the availability thereof, should be studied and analyzed to improve the robustness and resilience of our blood supply.

Feb 9, 2021, 01:00 AM by User Not Found

Bio-IT World | The computational biology team at St. Jude has published the latest on GenomePaint, one of the visualization features in the St. Jude Cloud platform, in the January issue of Cancer Cell.

Feb 5, 2021, 01:00 AM by User Not Found

Bio-IT World | Genetic sequence deletions help SARS-CoV-2 escape antibodies, molecular behavior of COVID-19 drugs, and the latest COVID-19 forecasts include two new variants. Plus: N439K variant shows two-fold increase in binding affinity and heparin inhibits SARS-CoV-2 spike protein, could be repurposed.